Significance of NF-κB/GATA Axis in Tumor Necrosis Factor-α-induced Expression of 6-Sulfated Cell Recognition Glycans in Human T-lymphocytes*
- 1 To whom correspondence should be addressed: Dept. of Molecular Pathology, Research Institute, Aichi Cancer Center, 1-1 Kanokoden, Chikusaku, Nagoya 464-8681, Japan. Tel. and Fax: 81-52-764-2973; E-mail: kannagi-gi{at}umin.ac.jp.
Abstract
Sulfated glycans play critical roles in various cell recognition events among leukocytes. The 6-sulfated lactosamine glycans in particular have been widely noted for their importance because they are involved in cell recognition events mediated by cell-adhesion molecules such as selectins and sialic acid-recognizing molecules such as siglecs and also in the activation of CD44 in binding to extracellular matrix hyaluronate. A pro-inflammatory cytokine, tumor necrosis factor-α, induces expression of 6-sulfated glycans on human leukocytes. Here we report that the transcription of the GlcNAc6ST-1 gene, the gene encoding a sulfotransferase for 6-sulfated glycan synthesis, is induced in human T-lymphoid cells through tandem NF-κB and GATA motifs in its 5′-regulatory region. Results of our reporter assays, immunoprecipitation, and chromatin immunoprecipitation analyses indicated that GATA-3 and/or GATA-2, but not GATA-1, associates with NF-κB in a transcription factor complex on the 5′-regulatory region of the gene and acts synergistically with NF-κB in triggering GlcNAc6ST-1 transcription. Recently, a skin-homing subset of helper memory T cells exhibiting the Th2 marker CCR4 was shown to specifically express 6-sulfated glycans. The transactivation mechanism described here suggested that GlcNAc6ST-1 transcription is coordinated with the NF-κB/GATA-3 axis, which is known to figure heavily in Th2 cell differentiation. In line with this, in vitro differentiation of human T cells to Th2 cells was found to significantly induce GlcNAc6ST-1 transcription and 6-sulfated glycan expression.
Footnotes
-
↵2 The abbreviations used are: IL, interleukin; TNF-α, tumor necrosis factor-α; LacNAc, N-acetyllactosamine; siRNA, small interfering RNA.
-
↵* This work was supported in part by grants-in-aid from the Ministry of Education, Science, Sports and Culture, Japan (19590298 and on priority areas 17015051), grants-in-aid for the Third-Term Comprehensive Ten-year Strategy for Cancer Control from the Ministry of Health and Welfare, Japan, a grant from the Nagono Medical Foundation, a grant from Mitsubishi Pharma Research Foundation, and a grant for the Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
- Received June 3, 2008.
- Revision received September 15, 2008.
- The American Society for Biochemistry and Molecular Biology, Inc.











